chr18-210001-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005151.4(USP14):c.1195G>A(p.Val399Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000491 in 1,607,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005151.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP14 | NM_005151.4 | c.1195G>A | p.Val399Ile | missense_variant | 14/16 | ENST00000261601.8 | NP_005142.1 | |
USP14 | NM_001037334.2 | c.1090G>A | p.Val364Ile | missense_variant | 13/15 | NP_001032411.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USP14 | ENST00000261601.8 | c.1195G>A | p.Val399Ile | missense_variant | 14/16 | 1 | NM_005151.4 | ENSP00000261601.6 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152098Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000406 AC: 10AN: 246180Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 132900
GnomAD4 exome AF: 0.0000357 AC: 52AN: 1455448Hom.: 0 Cov.: 28 AF XY: 0.0000332 AC XY: 24AN XY: 723830
GnomAD4 genome AF: 0.000178 AC: 27AN: 152098Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.1195G>A (p.V399I) alteration is located in exon 14 (coding exon 14) of the USP14 gene. This alteration results from a G to A substitution at nucleotide position 1195, causing the valine (V) at amino acid position 399 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at